Xarano ethacrynate sodium data

TELR (Wilmington, Mass.) announced preliminary Phase III results showing no statistical difference between the high and low dose treatment groups and the control group for both primary and secondary end points.

The primary end point was the mean change in pressure from baseline. Secondary end points included maximal increase in pressure and pressure spikes greater than 10 mm. The drug was given into the eyeball during the surgery. ...